MetaADEDB: ADE

MetaADEDB 2.0 @ LMMD

Mixed Tumor, Mullerian

(UMLS:C0206627)

Definition:: A tumor, basically a carcinoma with a single sarcoma such as leiomyosarcoma or angiosarcoma or multiple sarcomas of uterine origin. The role of estrogen has been postulated as a possible etiological factor in this tumor. (Holland et al., Cancer Medicine, 3d ed, p1703)
UMLS ID:: C0206627
MeSH ID:: D018200

Classification:

Name:

Neoplasms
MeSH Tree Number(s):: C04.557.435.540

Synonym(s)

Mixed Tumor, Mullerian

MULLERIAN MIXED TUMOR

Malignant mixed Mullerian tumor

Malignant mixed mesodermal tumor

Mixed Mesodermal (Mullerian) Neoplasm

Mixed Mesodermal (Mullerian) Tumor

Mixed Mesodermal (M眉llerian) Neoplasm

Mixed Mesodermal (M眉llerian) Tumor

Mixed Mullerian Tumor

10.

Mixed M眉llerian Tumor

11.

Mullerian mixed tumor

12.

Mullerian mixed tumour

13.

Mullerian tumor

14.

mixed mullerian tumor

15.

mixed mullerian tumors

16.

mixed mullerian tumour

17.

mullerian mixed tumor

18.

mullerian mixed tumour

Associated Drug(s)

	Name	Number of Reports	Reference(s)	Data Source
1	Raloxifene Hydrochloride		15863610	CTD
2	Tamoxifen		14709741	CTD

Similar ADE(s)

	Name	Semantic Similarity
1	Mesenchymoma	46.7%
2	Hepatoblastoma	46.7%
3	Carcinosarcoma	40.7%
4	leukemia	31%
5	Neoplasms, Germ Cell and Embryonal	31%
6	Neoplasms, Glandular and Epithelial	31%
7	Germ Cell Cancer	31%
8	Carcinoma 256, Walker	28.6%
9	Neuroectodermal Tumors	26.7%
10	Composite Lymphoma	26.3%
11	Thymoma	25.6%
12	Neoplasms, Neuroepithelial	24.6%
13	Gliomatosis cerebri	24.6%
14	Hemangiosarcoma	23.1%
15	lymphangiosarcoma	23.1%
16	Endometrial Stromal Sarcoma	22.9%
17	melanoma	22%
18	Histiocytic Disorders, Malignant	20.5%
19	Adenoma	20%
20	Ameloblastoma	20%
21	Angiokeratoma	20%
22	Carcinoma	20%
23	Chordoma	20%
24	Hemangioma	20%
25	hemangiopericytoma	20%
26	Lymphangioma	20%
27	Nevus	20%
28	Teratoma	20%
29	Germinoma	20%
30	Teratocarcinoma	20%
31	Angiofibroma	20%
32	Sarcoma	20%
33	Epithelioma	20%
34	Basal cell carcinoma	19.6%
35	Carcinoma, Papillary	19.6%
36	Squamous cell carcinoma	19.6%
37	Chondrosarcoma	19.6%
38	Craniopharyngioma	19.6%
39	Cystadenoma	19.6%
40	leiomyosarcoma	19.6%
41	liposarcoma	19.6%
42	Mesothelioma	19.6%
43	synovial sarcoma	19.6%
44	Neuroectodermal Tumor, Melanotic	19.6%
45	Angiomyolipoma	19.6%
46	Clear Cell Sarcoma of Soft Tissue	19.6%
47	Alveolar Soft Part Sarcoma	19.6%
48	Neuroendocrine Tumors	19.6%
49	Sarcoma, Myeloid	19.6%
50	Carcinoma, Basal Cell	19.6%
51	Adenoma, Acidophil	19.4%
52	Ganglioneuroma	19.4%
53	Glioma	19.4%
54	Malignant Glioma	19.4%
55	Medulloblastoma	19.1%
56	Hamartoma	18.5%
57	Neoplasms, Hormone-Dependent	18.5%
58	Neoplasms, Multiple Primary	18.5%
59	Paraneoplastic Syndromes	18.5%
60	Precancerous Conditions	18.5%
61	Neoplasms, Second Primary	18.5%
62	Carcinoid Tumor	18.1%
63	Neurilemmoma	18.1%
64	Hutchinson's Melanotic Freckle	18.1%
65	Melanoma, Amelanotic	18.1%
66	Cystadenocarcinoma	17.8%
67	Fibrosarcoma	17.8%
68	Osteosarcoma	17.8%
69	Mucoepidermoid Carcinoma	17.8%
70	Meningioma	17.4%
71	Leukemia, Plasma Cell	17.2%
72	Adenofibroma	17%
73	Fibroadenoma	17%
74	Malignant Fibrous Histiocytoma	17%
75	Carcinoma, Ehrlich Tumor	16.9%
76	Dermoid Cyst	16.9%
77	Carcinoma, Lewis Lung	16.9%
78	Astrocytoma	16.8%
79	Ependymoma	16.8%
80	oligodendroglioma	16.8%
81	Ganglioglioma	16.8%
82	gliosarcoma	16.8%
83	Anaplastic astrocytoma	16.8%
84	Anaplastic Oligodendroglioma	16.8%
85	Malignant Carcinoid Syndrome	16.2%
86	Bowen's Disease	16.1%
87	Paraganglioma	16.1%
88	Rhabdomyosarcoma	16.1%
89	Giant Cell Tumor of Bone	16.1%
90	Glioblastoma	15.5%
91	Neuroblastoma	15.5%
92	Glioblastoma Multiforme	15.5%
93	Melanoma, Experimental	15.5%
94	Dermatofibrosarcoma	15.3%
95	Dermatofibrosarcoma Protuberans	15.3%
96	Lymphoma	15.3%
97	Trophoblastic Neoplasms	15.3%
98	Leukemia, Experimental	15.1%
99	Ganglioneuroblastoma	14.9%
100	Adenocarcinoma	14.8%
101	Carcinoma in Situ	14.8%
102	Carcinoma, Transitional Cell	14.8%
103	Phyllodes Tumor	14.8%
104	Dysgerminoma	14.8%
105	Hemangioendothelioma	14.8%
106	Lipoma	14.8%
107	Myoma	14.8%
108	Myxoma	14.8%
109	Neuroma	14.8%
110	Papilloma	14.8%
111	Pseudomyxoma Peritonei	14.8%
112	Seminoma	14.8%
113	Papillomatosis	14.8%
114	Angiolipoma	14.8%
115	Myelolipoma	14.8%
116	Neoplasms, Bone Tissue	14.8%
117	Neoplasms, Fibrous Tissue	14.8%
118	Smooth Muscle Tumor	14.8%
119	Adenomatosis, Pulmonary	14.8%
120	Adenomatous Polyps	14.8%
121	Carcinoma, Large Cell	14.8%
122	Carcinoma, Small Cell	14.8%
123	Desmoplastic Small Round Cell Tumor	14.8%
124	Chondroma	14.8%
125	Enchondroma	14.8%
126	Pheochromocytoma	14.4%
127	Alveolar rhabdomyosarcoma	14.4%
128	Leukemia L1210	14.3%
129	Leukemia P388	14.3%
130	Acanthoma	14.3%
131	Mesoblastic Nephroma	14.1%
132	Choriocarcinoma	13.4%
133	Carcinoma, Lobular	13.4%
134	Plasmacytoma	13.3%
135	Nephroblastoma	13.3%
136	Malignant histiocytosis	13.2%
137	Histiocytic sarcoma	13.2%
138	Sarcoma 180	12.6%
139	Sarcoma, Experimental	12.5%
140	Carcinoid Heart Disease	12.4%
141	Leukemia, Radiation-Induced	12.2%
142	Adenoid Cystic Carcinoma	12.2%
143	Cyst	12.2%
144	fibroma	12.2%
145	Fibromatosis	12.2%
146	Neoplastic Processes	12.2%
147	Neoplastic Syndromes, Hereditary	12.2%
148	Osteoblastoma	12.2%
149	Osteoma	12.2%
150	Pregnancy Complications, Neoplastic	12.2%
151	Rhabdomyoma	12.2%
152	Chondromatosis	12.2%
153	Adenocarcinoma, Clear Cell	12.2%
154	Cholangiocarcinoma	12.2%
155	Cervical Intraepithelial Neoplasia	12.2%
156	Hemangioblastoma	12.2%
157	Lymphoma, Extranodal NK-T-Cell	12.2%
158	Neoplasms, Experimental	11.9%
159	Lymphangioleiomyomatosis	11.7%
160	Neurofibrosarcoma	11.6%
161	Retinoblastoma	11.1%
162	Fibromatosis, Aggressive	10.9%
163	Fibromatosis, Abdominal	10.9%
164	Klatskin Tumor	10.9%
165	Abdominal Neoplasms	10.3%
166	Erythroplasia	10.3%
167	Follicular cyst	10.3%
168	Head and Neck Neoplasms	10.3%
169	Mucocele	10.3%
170	Pilonidal Cyst	10.3%
171	Soft Tissue Neoplasms	10.3%
172	Thoracic Neoplasms	10.3%
173	Thyroglossal Cyst	10.3%
174	Synovial Cyst	10.3%
175	Aberrant Crypt Foci	10.3%
176	Hodgkin Disease	9.8%
177	Lymphoma, Non-Hodgkin	9.8%
178	Leukemia, Myelomonocytic, Chronic	9.8%
179	Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative	9.8%
180	Multiple Endocrine Neoplasia	9.2%
181	Neoplasms, Radiation-Induced	8.8%
182	Lymphomatoid Granulomatosis	8.8%
183	Paraneoplastic Encephalomyelitis	8.6%
184	Hydatidiform Mole	8.5%
185	Mammary Neoplasms, Experimental	8.4%
186	Acoustic Neuroma	8.4%
187	Carcinoma, Pancreatic Ductal	8.3%
188	Mastocytoma	8.2%
189	Mastocytosis, Systemic	8.1%
190	Leukemia, Myeloid, Chronic-Phase	8.1%
191	Primary amyloidosis	7.9%
192	Hepatocellular Adenoma	7.9%
193	Basal Cell Nevus Syndrome	7.7%
194	Mastocytosis	7.6%
195	Sturge-Weber Syndrome	7.6%
196	Optic Nerve Glioma	7.5%
197	Gastrointestinal Stromal Tumors	7.4%
198	Vipoma	7.4%
199	Hemangioma, Cavernous	7.4%
200	Digestive System Neoplasms	7.3%
201	Endocrine Gland Neoplasms	7.3%
202	Eye Neoplasms	7.3%
203	Leukemia, T-Cell	7.3%
204	Nervous System Neoplasms	7.3%
205	Leukemia, B-Cell	7.3%
206	neurofibroma	7.3%
207	Lymphoma, Follicular	7.3%
208	T-Cell Lymphoma	7.3%
209	Mantle cell lymphoma	7.3%
210	Bone neoplasms	7%
211	Leukoplakia	7%
212	Lymphocele	7%
213	Pancreatic Cyst	7%
214	Skin Neoplasms	7%
215	Hematologic Neoplasms	7%
216	Barrett Esophagus	6.8%
217	Breast Cyst	6.8%
218	Actinic keratosis	6.8%
219	Mediastinal Cyst	6.8%
220	Neoplasm Invasiveness	6.8%
221	Neoplasm Metastasis	6.8%
222	Neoplasm Recurrence, Local	6.8%
223	Parovarian Cyst	6.8%
224	Pericardial Cyst	6.8%
225	Splenic Neoplasms	6.8%
226	Thymic Cyst	6.8%
227	Carcinogenesis	6.8%
228	Myxoid cyst	6.8%
229	Metastasis	6.8%
230	Denys-Drash Syndrome	6.7%
231	Retroperitoneal Neoplasms	6.7%
232	Prolactinoma	6.5%
233	Growth Hormone-Secreting Pituitary Adenoma	6.5%
234	Tuberous Sclerosis	6.1%
235	Multiple Endocrine Neoplasia Type 1	6%
236	Precursor B-Cell Lymphoblastic Leukemia-Lymphoma	6%
237	Leukemia, Large Granular Lymphocytic	6%
238	Precursor T-Cell Lymphoblastic Leukemia-Lymphoma	6%
239	Lymphoma, T-Cell, Cutaneous	6%
240	Lymphoma, AIDS-Related	6%
241	Enteropathy-Associated T-Cell Lymphoma	6%
242	Primary Effusion Lymphoma	6%
243	insulinoma	5.7%
244	Waldenstrom Macroglobulinemia	5.7%
245	Multiple Myeloma	5.7%
246	Dupuytren Contracture	5.6%
247	granulosa cell tumor	5.5%
248	Carcinoma, Ovarian Epithelial	5.5%
249	Urticaria Pigmentosa	5.5%
250	Parathyroid Neoplasms	5.5%
251	Peritoneal Neoplasms	5.5%
252	Thyroid Neoplasm	5.5%
253	Thyroid carcinoma	5.5%
254	Gastrinoma	5.4%
255	Glucagonoma	5.4%
256	Mycosis Fungoides	5.4%
257	Lymphomatoid Papulosis	5.4%
258	Plasmablastic lymphoma	5.4%
259	Adrenocortical carcinoma	5.4%
260	Adenomatous Polyposis Coli	5.1%
261	Corpus Luteum Cyst	5%
262	Ovarian Cysts	5%
263	Liver Neoplasms, Experimental	5%
264	Leydig Cell Tumor	4.9%
265	Tracheal Neoplasms	4.8%
266	Leukoplakia, Oral	4.6%
267	Paraneoplastic Cerebellar Degeneration	4.6%
268	Pancreatic Neoplasm	4.6%
269	Renal Cell Carcinoma	4.6%
270	Papillary Renal Cell Carcinoma	4.6%
271	Mouth Neoplasms	4.5%
272	Central Nervous System Neoplasms	4.5%
273	Vascular Neoplasms	4.5%
274	Thymus Neoplasms	4.5%
275	Nasopharyngeal carcinoma	4.5%
276	Carcinoma, Endometrioid	4.4%
277	Genital Neoplasms, Female	4.4%
278	Pancreatic Pseudocyst	4.4%
279	Lymphatic Metastasis	4.4%
280	Neoplasms, Unknown Primary	4.4%
281	Leukemic Infiltration	4.4%
282	Breast Neoplasms, Male	4.4%
283	Neoplasm Micrometastasis	4.4%
284	Triple Negative Breast Neoplasms	4.4%
285	Choledochal Cyst	4.1%
286	Burkitt Lymphoma	4%
287	Peutz-Jeghers Syndrome	4%
288	Thyroid Nodule	3.9%
289	Esophageal Neoplasms	3.9%
290	Limbic Encephalitis	3.8%
291	Sezary Syndrome	3.6%
292	Adrenal Gland Neoplasms	3.4%
293	Gastrointestinal Neoplasms	3.4%
294	Genital Neoplasms, Male	3.4%
295	Liver neoplasms	3.4%
296	Uveal Neoplasms	3.4%
297	Urologic Neoplasms	3.4%
298	Lambert-Eaton Myasthenic Syndrome	3.3%
299	Testicular Neoplasms	3.3%
300	Sebaceous Gland Neoplasms	3.3%
301	Spinal Neoplasms	3.3%
302	Bone Marrow Neoplasms	3.3%
303	Meningeal Neoplasms	3.3%
304	Polycystic Ovary Syndrome	3.3%
305	Opsoclonus-Myoclonus Syndrome	2.9%
306	Meningeal Carcinomatosis	2.7%
307	Palatal Neoplasms	2.6%
308	Ear Neoplasms	2.6%
309	Eyelid Neoplasms	2.6%
310	Lung Neoplasms	2.6%
311	Pleural Neoplasms	2.6%
312	Myelitis, Transverse	2.6%
313	Nose Neoplasms	2.6%
314	Cell Transformation, Viral	2.5%
315	Brain Neoplasms	2.5%
316	Salivary Gland Neoplasms	2.5%
317	Spinal Cord Neoplasms	2.5%
318	Tongue Neoplasms	2.5%
319	Uterine Neoplasms	2.4%
320	Vaginal Neoplasms	2.4%
321	Vulvar Neoplasms	2.4%
322	Uterine Cancer	2.4%
323	Fallopian Tube Neoplasms	2.4%
324	Xeroderma Pigmentosum	2.2%
325	Pituitary Adenoma	2.2%
326	Pituitary Neoplasms	2.2%
327	ovarian neoplasm	2.2%
328	Bronchial Neoplasms	2.1%
329	Pharyngeal Neoplasms	2.1%
330	Multiple Pulmonary Nodules	2.1%
331	Supratentorial Neoplasms	2%
332	Central Nervous System Cysts	2%
333	Endometrial Neoplasms	2%
334	Bile Duct Neoplasms	2%
335	gallbladder neoplasm	2%
336	Intestinal Neoplasms	2%
337	Penile Neoplasms	2%
338	Prostatic Neoplasms	2%
339	Stomach Neoplasms	2%
340	Polycythemia Vera	1.9%
341	Brain Stem Neoplasms	1.8%
342	Laryngeal neoplasm	1.7%
343	Choroid Plexus Papilloma	1.7%
344	Hypopharyngeal Neoplasms	1.7%
345	Pleural Effusion, Malignant	1.7%
346	Hypopharyngeal Cancer	1.7%
347	Zollinger-Ellison syndrome	1.6%
348	Bladder Neoplasm	1.6%
349	Kidney Neoplasm	1.6%
350	Ureteral Neoplasms	1.6%
351	Urethral Neoplasms	1.6%
352	Parotid Neoplasms	1.6%
353	Prostatic Neoplasms, Castration-Resistant	1.6%
354	Nelson Syndrome	1.6%
355	Tonsillar Neoplasms	1.5%
356	Cerebellar Neoplasms	1.4%
357	Cecal Neoplasms	1.3%
358	Duodenal Neoplasms	1.3%
359	Radicular Cyst	1.2%
360	Appendiceal Neoplasms	1.2%
361	Colonic Neoplasms	1.2%
362	Rectal Neoplasms	1.2%
363	Nasopharyngeal Neoplasms	1.2%
364	Colorectal Neoplasms	1.2%
365	Paranasal Sinus Neoplasms	1%
366	Anus Neoplasms	1%
367	Sigmoid Neoplasms	1%
368	Maxillary Sinus Neoplasms	0.9%

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120234